Adenovirus-mediated combined anti-angiogenic and pro-apoptotic gene therapy enhances antitumor efficacy in hepatocellular carcinoma

Oncology Letters

Volumn 5, Issue 1, 2012, Pages 348-354

  Yan, Fei ^a,b   Zheng, Yi ^a   Huang, Laiqiang ^a  

^a TSINGHUA UNIVERSITY   (China)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

Author keywords

Adenovirus; Cancer gene therapy; Endostrain; Hepatocellular carcinoma; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

ADENOVIRUS VECTOR; ENDOSTATIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC GENE THERAPY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HEK293; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; EXPRESSION VECTOR; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VOLUME; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL; VIRAL GENE THERAPY; VIRUS RECOMBINANT; WESTERN BLOTTING;

EID: 84869047825     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.987     Document Type: Article

References (31)

1. Cha C, DeMatteo RP and Blumgart LH: Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol 35 (Suppl 2): S130-S137, 2002.
2. Forner A, Llovet JM and Bruix J: Hepatocellular carcinoma. Lancet 379: 1245-1255, 2012.
3. El-Serag HB: Hepatocellular carcinoma. N Engl J Med 365: 1118-1127, 2011.
4. Carr BI: Hepatocellular carcinoma: current management and future trends. Gastroenterology 127: S218-S224, 2004.
5. Di Maio M, De Maio E, Perrone F, Pignata S and Daniele B: Hepatocellular carcinoma; systemic treatments. J Clin Gastroenterol 35 (Suppl 2): S109-S114, 2002.
6. Prieto J, Qian C, Hernandez-Alcoceba R, Gonzalez-Aseguinolaza G, Mazzolini G, Sangro B and Kramer MG: Gene therapy of liver diseases. Expert Opin Biol Ther 4: 1073-1091, 2004.
7. Hernández-Alcoceba R, Sangro B and Prieto J: Gene therapy of liver cancer. Ann Hepatol 6: 5-14, 2007.
8. Cosman D: A family of ligands for TNF receptor superfamily. Stem Cells 12: 440-445, 1994.
9. Ashkenazi A and Dixit VM: Death receptors: signaling and modulation. Science 281: 1305-1308, 1998.
10. Walczak H, Miller RE, Ariail K, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163, 1999.
11. Piras V, Hayashi K, Tomita M and Selvarajoo K: Enhancing apoptosis in TRAIL-resistant cancer cells using fundamental response rules. Sci Rep 1: 144, 2011.
12. Yang A, Wilson NS and Ashkenazi A: Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation. Curr Opin Cell Biol 22: 837-844, 2010.
13. Nagane M, Huang HJ and Cavenee WK: The potential of TRAIL for cancer chemotherapy. Apoptosis 6: 191-197, 2001.
14. Yamaguchi N: An analysis of the functional mechanisms of endostatin-the anti-angiogenic activity of endostatin is mediated by its multiple binding ability. Connect Tissue 36: 171-178, 2004.
15. O'Reilly MS, Boehm T, Shing Y, et al: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997.
16. Yamaguchi N, Anand-Apte B, Lee M, et al: Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18: 4414-4423, 1999.
17. Bao Y, Feng WM, Tang CW, Zheng YY, Gong HB and Hou EG: Endostatin inhibits angiogenesis in hepatocellular carcinoma after transarterial chemoembolization. Hepatogastroenterology 59: 1566-1568, 2012.
18. Franceschi RT and Ge C: Gene delivery by adenoviruses. Methods Mol Biol 455: 137-147, 2008.
19. Lee J and Moon C: Current status of experimental therapeutics for head and neck cancer. Exp Biol Med 236: 375-389, 2011.
20. Zhang Y, Qu ZH, Cui M, Guo C, Zhang XM, Ma CH and Sun WS: Combined endostatin and TRAIL gene transfer suppresses human hepatocellular carcinoma growth and angiogenesis in nude mice. Cancer Biol Ther 8: 466-473, 2009.
21. Wei YQ, Wang QR, Zhao X, et al: Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 6: 1160-1166, 2000.
22. Wei YQ, Huang MJ, Yang L, et al: Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA 98: 11545-11550, 2001.
23. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H and Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348: 555-557, 1990.
24. O'Reilly MS, Holmgren L, Shing Y, et al: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328, 1994.
25. Sauter BV, Martinet O, Zhang WJ, Mandeli J and Woo SL: Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci USA 97: 4802-4807, 2000.
26. Lin T, Zhang L, Davis J, et al: Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers. Mol Ther 8: 441-448, 2003.
27. Wissink EH, Verbrugge I, Vink SR, et al: TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy. Radiother Oncol 80: 214-222, 2006.
28. Wu DS, Wu CM, Huang TH and Xie QD: Combined effects of radiotherapy and endostatin gene therapy in melanoma tumor model. Radiat Environ Biophys 47: 285-291, 2008.
29. Zhu LP, Xing J, Wang QX, et al: Therapeutic efficacy of recombinant human endostatin combined with chemotherapeutics in mice-transplanted tumors. Eur J Pharmacol 617: 23-27, 2009.
30. Kim Y: The effects of nutrient depleted microenvironments and delta-like 1 homologue (DLK1) on apoptosis in neuroblastoma. Nutr Res Pract 4: 455-461, 2010.
31. Braun F, Bertin-Ciftci J, Gallouet AS, Millour J and Juin P: Serum-nutrient starvation induces cell death mediated by Bax and Puma that is counteracted by p21 and unmasked by Bcl-xL inhibition. PLoS One 6: e23577, 2011.